A simple three-step purification procedure for interleukin 3 involving absorption to fixed cells

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Interleukin-3 (IL-3) is a critical cytokine for hematopoiesis.
• Efficient purification methods are needed for studying IL-3's biological functions.
• Existing methods for IL-3 purification can be complex and yield low purity.

Purpose of the Study:

• To develop a novel solid-phase reagent for large-scale purification of murine IL-3 (mIL-3).
• To characterize the purified mIL-3 and elucidate its different molecular forms.

Main Methods:

• Treatment of B6SUtA1 cells with glutaraldehyde to create mechanically resistant spheres.
• Affinity purification using modified B6SUtA1 cells as a solid phase.
• Chromatographic techniques including Sephadex G75 and reverse-phase HPLC (C18 column).
• N-glycanase treatment and competition studies with recombinant mIL-3 and GM-CSF.

Main Results:

• Glutaraldehyde treatment yielded mechanically resistant B6SUtA1 cells suitable for solid-phase purification.
• mIL-3 was purified approximately 16,000-fold from conditioned medium with a 16% yield.
• Purified mIL-3 consisted of two protein species (19.5 and 16.5 kd) with mIL-3-like activity.
• N-glycanase treatment converted the 19.5-kd species to the 16.5-kd species, indicating differential glycosylation.
• Binding was specific to mIL-3, as demonstrated by competition studies with recombinant mIL-3.

Conclusions:

• Glutaraldehyde-treated B6SUtA1 cells provide an effective solid-phase reagent for mIL-3 purification.
• The purified mIL-3 exists in at least two glycosylated forms.
• This method offers a significant advancement for obtaining highly purified mIL-3 for research purposes.